Trump drug price executive order: Winners and losersnews2025-04-16T18:38:40+00:00April 16th, 2025|Endpoints News|
Biotech, CDMOs start to disclose tariff exposure with US trade inquiry underway news2025-04-16T12:43:58+00:00April 16th, 2025|Endpoints News|
ACIP meeting: CDC ‘scraping’ to respond to measles; FDA comments on Novavaxnews2025-04-15T23:28:26+00:00April 15th, 2025|Endpoints News|
Trump pledges support for changing IRA ‘pill penalty,’ siding with pharmanews2025-04-15T21:36:53+00:00April 15th, 2025|Endpoints News|
Biogen, Eisai’s Leqembi wins EU authorization for some patientsnews2025-04-15T19:42:35+00:00April 15th, 2025|Endpoints News|
J&J CEO chides Trump’s tariff plan to boost US drugmakingnews2025-04-15T18:53:47+00:00April 15th, 2025|Endpoints News|
State attorneys general urge Congress to bar PBMs from owning pharmaciesnews2025-04-15T17:58:23+00:00April 15th, 2025|Endpoints News|
Trump’s pharma probe sweeps in APIs, ‘key starting materials’news2025-04-15T16:54:42+00:00April 15th, 2025|Endpoints News|
J&J maintains EPS, raises sales outlook under shadow of looming pharma tariffsnews2025-04-15T11:20:29+00:00April 15th, 2025|Endpoints News|
Small biotech Oak Hill will bring Roche’s Angelman drug back to lifenews2025-04-15T11:00:21+00:00April 15th, 2025|Endpoints News|
